News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Johnson Bankole A.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/02/2023 |
4
| Johnson Bankole A. (Director) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns:
| Granted 40,000 options
@ $0.3025, valued at
$12.1k
|
|
02/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/13/2019 |
4
| Johnson Bankole A. (Chief Medical Officer) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns:
| Sold 150,000 shares
@ $1, valued at
$150k
|
|
10/04/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/01/2019 |
4
| Johnson Bankole A. (Chief Medical Officer) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns:
| Bought 40,000 shares
@ $3.1452, valued at
$125.8k
Bought 30,000 shares
@ $3.4718, valued at
$104.2k
Bought 2,500 shares
@ $3.4676, valued at
$8.7k
Bought 600 shares
@ $3.2967, valued at
$2k
|
|
04/01/2019 |
SC 13D/A
| Johnson Bankole A. reports a 8.3% stake in ADIAL PHARMACEUTICALS, INC. |
03/26/2019 |
4
| Johnson Bankole A. (Chief Medical Officer) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns:
| Granted 250,000 options
@ $3.01, valued at
$752.5k
|
|
11/14/2018 |
SC 13D
| Johnson Bankole A. reports a 22.3% stake in ADIAL PHARMACEUTICALS, INC. |
11/13/2018 |
4
| Johnson Bankole A. (10% Owner) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns:
| Disposed of 17,600 options to buy
@ $5, valued at
$88k
Acquired 17,600 options to buy
@ $5, valued at
$88k
Acquired 17,600 options to buy
@ $6.25, valued at
$110k
|
|
07/26/2018 |
3
| Johnson Bankole A. (10% Owner) has filed a Form 3 on ADIAL PHARMACEUTICALS, INC. |
|
|